Skip to main content


Forestar Group

(FOR) - Get Forestar Group Inc. Report

was upgraded to buy at TheStreet Ratings.

Northeast Bancorp

(NBN) - Get Northeast Bank Report

was downgraded to hold at TheStreet Ratings.


(INTC) - Get Intel Corporation Report

earnings estimates were reduced at UBS. The lowered outlook reflects a sub-seasonal PC client trend, said UBS. Price target remains $22.50.

Onyx Pharmaceuticals


price target was increased to $105 by JPMorgan. Palbociclib (palbo, or PD-991), a breast cancer drug, is now included in the valuation, said JPMorgan.


(VRSN) - Get VeriSign, Inc. Report

price target was increased to $50 at Citigroup. The new price target reflects the likelihood of a significant debt raise, said Citigroup.

Scroll to Continue

TheStreet Recommends


(Z) - Get Zillow Group, Inc. Class C Report

price target increased at Citi. The initial mid-term outlook provided at Z's fist analyst day led to a new price target of $70, said Citigroup.

Red Hat

( RHAT) estimates and price target cut at MKM. RHT earnings estimates through 2014 were reduced on management guidance, said MKM Partners. The new price target is $53.

Progress Software

(PRGS) - Get Progress Software Corporation Report

price target was reduced to $29 at Benchmark. Lower fiscal 2Q guidance reflects uncertainty related to its ongoing business transformation, said Benchmark.

Verint Systems

(VRNT) - Get Verint Systems Inc. Report

estimates and price target increased at JPMorgan. VRNT fourth quarter earnings were better than expected and outlook was solid, said JPMorgan. Earnings estimates were increased and the price target was bumped to $41.

Five Below

(FIVE) - Get Five Below, Inc. Report

estimates reduced at UBS on weaker than expected guidance from management. The new outlook includes investments for growth, said UBS. Price target remains $35.

Ryder Systems

(R) - Get Ryder System, Inc. Report

estimates and price target were increased at KeyBanc to reflect a favorable lease pipeline. Price target goes to $68.

Bed Bath & Beyond

(BBBY) - Get Bed Bath & Beyond Inc. Report

estimates reduced at Oppenheimer ahead of the earnings release. Sales and margin weakness have likely persisted, said Oppenheimer

>To submit a news tip, email:



>>Hess: From a Mess to a Prize

>>Facebook, the Gaming Network





and become a fan on


This article was written by a staff member of TheStreet.